The management of Candida infections in preterm neonates and the role of micafungin

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 24, Issue SUPPL. 2, 2011, Pages 25-28

  Manzoni, Paolo ^a   Benjamin, Daniel K ^b   Hope, William ^c   Rizzollo, Stefano ^a   Sordo, Paola Del ^a   Stronati, Mauro ^d   Jacqz Aigrain, Evelyne ^e   Castagnola, Elio ^f   Farina, Daniele ^a  

^a S ANNA HOSPITAL   (Italy)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

^d FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^e HÔPITAL ROBERT DEBRÉ   (France)

^f G GASLINI INSTITUTE   (Italy)

Author keywords

Candida; Echinocandin; Infection; Micafungin; Neonate

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; AMPHOTERICIN B LIPID COMPLEX; CASPOFUNGIN; FLUCONAZOLE; FLUCYTOSINE; MICAFUNGIN; VORICONAZOLE;

AREA UNDER THE CURVE; BIOFILM; BLOOD BRAIN BARRIER; BLOOD CULTURE; BONE MARROW TOXICITY; CANDIDA GLABRATA; CATHETER REMOVAL; CENTRAL VENOUS CATHETERIZATION; CROSS RESISTANCE; DRUG EFFICACY; DRUG SAFETY; EXTREMELY LOW BIRTH WEIGHT; FUNGUS ISOLATION; HUMAN; INVASIVE CANDIDIASIS; LIVER TUMOR; NEPHROTOXICITY; NEWBORN INTENSIVE CARE; PREMATURITY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; REVIEW; SALVAGE THERAPY; SIDE EFFECT; SINGLE DRUG DOSE; TOTAL PARENTERAL NUTRITION;

EID: 80053533717     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Benjamin DK Jr, Stoll BJ, Fanaroff AA, McDonald SA, Oh W, Higgins RD, Duara S, et al.; National Institute of Child Health and Human Development Neonatal Research Network. Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months. Pediatrics 2006;117:84-92. (Pubitemid 46050523)
2. Zaoutis TE, Heydon K, Localio R, Walsh TJ, Feudtner C. Outcomes attributable to neonatal candidiasis. Clin Infect Dis 2007;44:1187-1193. (Pubitemid 46651243)
3. Manzoni P, Farina D, Leonessa M, dOulx EA, Galletto P, Mostert M, Miniero R, Gomirato G. Risk factors for progression to invasive fungal infection in preterm neonates with fungal colonization. Pediatrics 2006;118:2359-2364. (Pubitemid 46397574)
4. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, OGrady NP, Raad II, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1-45.
5. Queiroz-Telles F, Berezin E, Leverger G, Freire A, van der Vyver A, Chotpitayasunondh T, Konja J, et al.; Micafungin Invasive Candidiasis Study Group. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized doubleblind trial. Pediatr Infect Dis J 2008;27:820-826.
6. Benjamin DK Jr, Smith PB, Arrieta A, Castro L, Sánchez PJ, Kaufman D, Arnold LJ, et al. Safety and pharmacokinetics of repeat-dose micafungin in young infants. Clin Pharmacol Ther 2010;87:93-99.
7. Hope WW, Smith PB, Arrieta A, Buell DN, Roy M, Kaibara A, Walsh TJ, et al. Population pharmacokinetics of micafungin in neonates and young infants. Antimicrob Agents Chemother 2010;54:2633-2637.
8. Yanni SB, Smith PB, Benjamin DK Jr, Augustijns PF, Thakker DR, Annaert PP. Higher clearance of micafungin in neonates compared with adults: role of age-dependent micafungin serum binding. Biopharm Drug Dispos 2011;32:222-232.
9. Hope WW, Mickiene D, Petraitis V, Petraitiene R, Kelaher AM, Hughes JE, Cotton MP, et al. The pharmacokinetics and pharmacodynamics of micafungin in experimental hematogenous Candida meningoencephalitis: implications for echinocandin therapy in neonates. J Infect Dis 2008;197:163-171. (Pubitemid 351263481)
10. Ascher S, Smith PB, Benjamin DK Jr. Safety of micafungin in infants: insights into optimal dosing. Expert Opin Drug Saf 2011;10:281-286.
11. Smith PB, Walsh TJ, Hope W, Arrieta A, Takada A, Kovanda LL, Kearns GL, et al. Pharmacokinetics of an elevated dosage of micafungin in premature neonates. Pediatr Infect Dis J 2009;28:412-415.
12. Hope W. 2011, personal communication
13. Pappas PG, Rostein CM, Betts RF, Nucci M, Talwar D, De Waele JJ, Vazquez JA, et al. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis. Clin Infect Dis 2007;45:883-893. (Pubitemid 47580382)
14. TINN Consortium. A European survey on the practices regarding fluconazole use in preterm neonates. 2011, in press.
15. Manzoni P, Farina D, Galletto P, Leonessa M, Priolo C, Arisio R, Gomirato G. Type and number of sites colonized by fungi and risk of progression to invasive fungal infection in preterm neonates in neonatal intensive care unit. J Perinat Med 2007;35:220-226. (Pubitemid 46700985)
16. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002;46:1773-1780. (Pubitemid 34535196)
17. Karlowicz MG, Hashimoto LN, Kelly RE Jr, Buescher ES. Should central venous catheters be removed as soon as candidemia is detected in neonates? Pediatrics 2000;106:E63.
18. Nucci M, Anaissie E. Should vascular catheters be removed from all patients with candidemia? An evidence-based review. Clin Infect Dis 2002;34:591-599. (Pubitemid 34165320)
19. Castagnola E, Franceschi A, Natalizia AR, Mantero E, Tuo P. Combined antifungal therapy for persistent central venous catheter-related candidemia in extremely low birth weight neonates. J Chemother 2009;21:234-235.
20. Lauren A. Burwell, David Kaufman, Jennifer Blakely, Barbara J. Stoll, and Scott K. Fridkin. Antifungal Prophylaxis to Prevent Neonatal Candidiasis: a Survey of Perinatal Physician Practices. Pediatrics 2006; 118:4: e1019-e1026. (Pubitemid 46393750)
21. Manzoni P, Rizzollo S, Franco C, Gallo E, Galletto P, Boano E, Mostert M. et al. Role of echinocandins in the management of fungal infections in neonates. J Matern Fetal Neonatal Med 2010;23 Suppl 3:49-52.
22. Benjamin DK Jr, Poole C, Steinbach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisal of the literature using meta-analytic techniques. Pediatrics 2003;112: 634-640. (Pubitemid 37082118)
23. Manzoni P, Maestri A, Leonessa M, Mostert M, Farina D, Gomirato G. Fungal and bacterial sepsis and threshold ROP in preterm very low birth weight neonates. J Perinatol 2006;26:23-30. (Pubitemid 43135251)
24. Kaufman DA, Cuff AL, Wamstad JB, Boyle R, Gurka MJ, Grossman LB, Patrick P. Fluconazole prophylaxis in extremely low birth weight infants and neurodevelopmental outcomes and quality of life at 8 to 10 years of age. J Pediatr 2011;158:759-765.e1.
25. Benjamin DK Jr, Miro JM, Hoen B, Steinbach WJ, Fowler VG Jr, Olaison L, Habib G, et al.; ICE-MD Study Group. Candida endocarditis: contemporary cases from the International Collaboration of Infectious Endocarditis Merged Database (ICE-mD). Scand J Infect Dis 2004;36:453-455. (Pubitemid 39089195)
26. Natale F, Castronovo A, Regoli D, De Curtis M, Manzoni P. Successful treatment with caspofungin of refractory Candida krusei candidemia in a very low birth weight preterm infant. Pediatr Infect Dis J 2009;28:452.